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Background: Concomitant presence of coronary artery disease (CAD) and atrial fibrillation (AF) portends higher risk of cardiovascular events. 
Atherosclerosis and AF both associated with heightened systemic inflammatory activity. We sought to determine if the presence of AF is associated 
with increased progression of coronary atherosclerosis in patients with CAD.
Methods: 3469 patients with CAD underwent serial intravascular ultrasound to monitor changes in atheroma burden in 7 clinical trials of 
atherosclerotic therapies. Patients with history of AF (n=120) were propensity matched according to CAD risk factors to patients without AF (n=360). 
Groups were compared with regard to coronary atheroma burden at baseline and change on serial evaluation.
Results: Patients with AF were more likely to have a history of stroke, heart failure and had a higher BMI. Baseline medication was comparable 
between groups. AF patients demonstrated less plaque burden, larger lumen volumes and similar vessel volumes (Table). Changes in percent 
atheroma volume (PAV, +0.82±0.5 vs +0.36±0.5 %, p=0.16) and total atheroma volume (TAV, -1.14±3.1 vs -3.4±2.8 mm3, p=0.16) observed similar 
between groups.
Conclusions: AF patients had less plaque burden and no greater atheroma progression on follow-up. This supports the use of established 
antiatherosclerotic therapies on patients with concomitant AF and CAD. The presence of AF is also associated with a greater likelihood of expansive 
remodeling.
Baseline clinical characteristics and IVUS measurements in subjects with or without AF
Characteristic AFib (n=120) No-Afib (n=360) p Value
Age (yrs) 62.7±9.0 61.3±9.3 0.15
Female (%) 25.0 29.4 0.35
History of CVA (%) 8.3 3.1 0.01
History of CHF (%) 11.7 4.4 0.005
BMI (kg/m2) 32.0 ±6.01 30.4±5.6 0.004
PAV (%) 36.1±8.9 39.1±9.1 0.002
TAV (mm3) 181±91.2 190±81.8.0 0.12
EEM Volume (mm3) 488.1±173.5 480.6±160.5 0.85
Lumen Volume (mm3) 306.7±101.4 290.2±101.6 0.07
